Meeting of the Drug Control Research, Data, and Evaluation Committee

---
identifier: "/us/fr/01-31055"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Meeting of the Drug Control Research, Data, and Evaluation Committee"
title_number: 0
title_name: "Federal Register"
section_number: "01-31055"
section_name: "Meeting of the Drug Control Research, Data, and Evaluation Committee"
positive_law: false
currency: "2001-12-18"
last_updated: "2001-12-18"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Office of National Drug Control Policy"
document_number: "01-31055"
document_type: "notice"
publication_date: "2001-12-18"
agencies:
  - "Office of National Drug Control Policy"
fr_citation: "66 FR 65210"
fr_volume: 66
comments_close_date: "2002-01-17"
fr_action: "Notice of meeting."
---


#  Meeting of the Drug Control Research, Data, and Evaluation Committee

**AGENCY:**

Office of National Drug Control Policy.

**ACTION:**

Notice of meeting.

**SUMMARY:**

ONDCP will convene a meeting of the Drug Control Research, Data, and Evaluation Advisory Committee on January 17-18, 2002, at the White House Conference Center located at 726 Jackson Place, NW., Washington, DC. The meeting will begin promptly each day at 9 am and adjourn at 4 pm. The agenda will include general discussion and briefs on national drug use indicators and other federal drug control initiatives including, but not limited to the following: (1) Interagency Oxycontin Work Group Progress Report on an Early Warning System for Pharmaceutical Diversion Abuse; (2) a Redesign Proposal for the Drug Abuse Warning Network (DAWN); (3) ONDCP's Anti-Drug Media Campaign Evaluation; (4) 2001 National Household Survey on Drug Abuse State Estimates of Treatment Need and Drug Use Prevalence; (5) The RAMONA Project (Random Access Monitoring of Narcotics Addicts); (6) HHS's Report on Closing the Drug Abuse Treatment Gap: A Report to the President of the U.S.; (7) Updates on Drug Free Communities Grant Program; and (8) Activities related to: prevention, families, schools, and workplaces. There will be an opportunity for public comment from 11:30 am to 12 Noon on Thursday, January 17, 2002.

**DATES:**

January 17-18, 2002, 9 am to 4:00 pm. Opportunity for public comment from 11:30 am to 12:00 noon on Thursday, January 17, 2002.

**ADDRESSES:**

White House Conference Center, 726 Jackson Place, NW, Washington, DC.

**FOR FURTHER INFORMATION CONTACT:**

Linda V. Priebe, Assistant General Counsel, Office of National Drug Control Policy, Washington, DC (202) 395-6622.

Dated: December 11, 2001.

Linda V. Priebe,

Assistant General Counsel.